Subscribe
shutterstock_1397823587_pavel_kapysh
Pavel Kapysh / Shutterstock.com
21 December 2021AmericasAlex Baldwin

BioDelivery Sciences ‘pleased’ with mixed ruling over Opioid drug claims

A Delaware Federal Court has upheld some of the validity of challenged claims in two patents related to BioDelivery Sciences’ (BDSI) opioid medication Belbuca (buprenorphine), but invalidated others.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Monosol sues BioDelivery over pain treatment
17 January 2017   Monosol Rx, a speciality pharmaceutical company, has filed a complaint against BioDelivery Sciences International for alleged patent infringement.
Americas
Teva sued over opioid overdose drug
25 October 2016   Irish pharmaceutical company Adapt Pharma has filed a complaint against Teva for allegedly infringing a patent centring on its nasal spray Narcan.


Editor's picks

A step too far? Why Stewart’s approach is dividing opinion
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

Editor's picks

Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Counsel grapple with AI’s impact on training and critical thinking
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025

More on this story

Americas
Monosol sues BioDelivery over pain treatment
17 January 2017   Monosol Rx, a speciality pharmaceutical company, has filed a complaint against BioDelivery Sciences International for alleged patent infringement.
Americas
Teva sued over opioid overdose drug
25 October 2016   Irish pharmaceutical company Adapt Pharma has filed a complaint against Teva for allegedly infringing a patent centring on its nasal spray Narcan.

More on this story

Americas
Monosol sues BioDelivery over pain treatment
17 January 2017   Monosol Rx, a speciality pharmaceutical company, has filed a complaint against BioDelivery Sciences International for alleged patent infringement.
Americas
Teva sued over opioid overdose drug
25 October 2016   Irish pharmaceutical company Adapt Pharma has filed a complaint against Teva for allegedly infringing a patent centring on its nasal spray Narcan.

More features

Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?
Broad Institute wins appeal to restore CRISPR patent in Europe
BMS faces fresh lawsuit over alleged cancer drug monopoly
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations
Boies Schiller Flexner adds three-strong litigation team